Premium
Global Economic and Health Benefits of Tobacco Control: Part 1
Author(s) -
Wipfli H,
Samet J M
Publication year - 2009
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2009.93
Subject(s) - tobacco control , pandemic , scope (computer science) , environmental health , tobacco use , global health , psychological intervention , public health , medicine , covid-19 , economic growth , disease , economics , infectious disease (medical specialty) , population , nursing , pathology , psychiatry , computer science , programming language
Although the risks of tobacco smoking have been known for decades, the pandemic of tobacco use continues. There are an estimated 1.3 billion smokers worldwide, along with millions more using various oral tobacco products. Recent global estimates place the mortality burden from tobacco use at over 6 million annually, with nearly two‐thirds of these deaths occurring in developing countries. If current patterns persist, there will be an estimated 1 billion deaths from tobacco during the twenty‐first century. Part 1 of this two‐part paper provides an overview of the tobacco pandemic, the scope of the pandemic, and its economic and health consequences. Part 2 reviews the history of tobacco control to date and addresses the current global strategy, based on the World Health Organization's (WHO's) Framework Convention on Tobacco Control and the MPOWER package of interventions. Part 2 ends with a consideration of scenarios for the future of the pandemic. Clinical Pharmacology & Therapeutics (2009); 86 3, 263–271. doi: 10.1038/clpt.2009.93